Wells Fargo & Company Pharming Group N.V. Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding PHAR
# of Institutions
5Shares Held
66.9KCall Options Held
0Put Options Held
0-
Silverberg Bernstein Capital Management LLC Armonk, NY41.1KShares$433,7100.31% of portfolio
-
Cowen Prime Advisors LLC22.5KShares$236,9530.09% of portfolio
-
Morgan Stanley New York, NY3.3KShares$34,8150.0% of portfolio
-
Farther Finance Advisors, LLC San Francisco, CA11Shares$1160.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About Pharming Group N.V.
- Ticker PHAR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,241,400
- Market Cap $688M
- Description
- Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the tre...